Single-cell transcriptomic analysis of SARS-CoV-2 reactive CD4 + T cells
Biorxiv : the Preprint Server for Biology
|June 27, 2020
Summary
CD4+ T cells play a key role in COVID-19 immunity. Severe disease is linked to more cytotoxic T helper cells (CD4-CTLs) and fewer regulatory T cells, impacting immune cell recruitment.
Area of Science:
- Immunology
- Virology
- Genomics
Background:
- The role of CD4+ T cells in protective or pathogenic immune responses to SARS-CoV-2 infection is not fully understood.
- Understanding these cellular dynamics is crucial for developing effective COVID-19 treatments and vaccines.
Approach:
- Conducted large-scale single-cell transcriptomic analysis of viral antigen-reactive CD4+ T cells from 32 COVID-19 patients.
- Compared immune cell profiles between patients with mild and severe COVID-19 disease.
Key Points:
- Severe COVID-19 showed increased cytotoxic follicular helper (T_FH) cells and cytotoxic T helper cells (CD4-CTLs) reactive to SARS-CoV-2.
- Reduced proportions of SARS-CoV-2 reactive regulatory T cells were observed in severe cases.
- CD4-CTLs highly expressed chemokines for myeloid and dendritic cell recruitment to infection sites.
- T helper 1 (T_H1) and T helper 17 (T_H17) cells were underrepresented compared to influenza-reactive T cells.
Conclusions:
- This study provides unprecedented insights into the gene expression patterns of SARS-CoV-2 reactive CD4+ T cells across different disease severities.
- Findings highlight distinct CD4+ T cell subset contributions to COVID-19 pathogenesis and immunity.
More Related Videos
06:03Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
1.6K
09:08Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
6.1K
